logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
Showing 1 - 14 of 14 Items
Showing 1 - 14 of 14 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Evaluation of a decentralised model of care on case isolation and patient outcomes during the 2018–20 Ebola outbreak in the Democratic Republic of the Congo: a retrospective observational study

Barks PM, Camacho A, Newport T, Ribeiro F, Ahuka-Mundeke S,  et al.
2025-03-25 • Lancet Global Health
2025-03-25 • Lancet Global Health
Journal Article
|
Research

Rapid decision algorithm for patient triage during Ebola outbreaks

Ardiet DL, Nsio J, Komanda G, Coulborn RM, Grellety E,  et al.
2024-11-01 • Emerging Infectious Diseases
2024-11-01 • Emerging Infectious Diseases

The low specificity of Ebola virus disease clinical signs increases the risk for nosocomial transmission to patients and healthcare workers during outbreaks. Reducing this risk requir...

Journal Article
|
Short Report

Evaluation of centralised and decentralised models of care during the 2020 Ebola Virus Disease outbreak in Equateur Province, Democratic Republic of the Congo: A brief report

Lampaert E, Nsio JM, Nair D, Mashako M, De Weggheleire A,  et al.
2024-08-28 • F1000Research
2024-08-28 • F1000Research

BACKGROUND

Tradi...

Journal Article
|
Case Report/Series

Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn RM,  et al.
2024-08-01 • Lancet Infectious Diseases
2024-08-01 • Lancet Infectious Diseases

BACKRGOUND

The rec...

Conference Material
|
Abstract

Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo

Coulborn RM
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
BACKGROUND
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease (EVD) outbreaks. This study aimed to assess the protective effect of the vaccine aga...
Journal Article
|
Commentary

Measles and rubella vaccine microneedle patch: new hope to reach the unreached children

Coulborn RM, Danet C, Alsalhani A
2024-04-29 • Lancet
2024-04-29 • Lancet
Worldwide, more than 99% of the burden of measles infections and deaths affects populations in low-income and middle-income countries. Measles accounts for 3% of the global mortality of ...
Journal Article
|
Research

Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo

Coulborn RM, Bastard M, Peyraud N, Gignoux EM, Luquero FJ,  et al.
2024-02-01 • Lancet Infectious Diseases
2024-02-01 • Lancet Infectious Diseases
BACKGROUND
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of ...
Journal Article
|
Research

Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study

Nsio JM, Ardiet DL, Coulborn RM, Grellety E, Albela M,  et al.
2023-01-01 • Lancet Infectious Diseases
2023-01-01 • Lancet Infectious Diseases
BACKGROUND
In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses. We aime...
Journal Article
|
Research

Feasibility of using teleradiology to improve tuberculosis screening and case management in a district hospital in Malawi

Coulborn RM, Panunzi I, Spijker S, Brant WE, Trivino Duran L,  et al.
2012-06-21 • Bulletin of the World Health Organization
2012-06-21 • Bulletin of the World Health Organization
Malawi has one of the world's highest rates of human immunodeficiency virus (HIV) infection (10.6%), and southern Malawi, where Thyolo district is located, bears the highest burden in th...
Journal Article
|
Research

Field challenges to measles elimination in the Democratic Republic of the Congo

Coulborn RM, Nackers F, Bachy C, Porten K, Vochten H,  et al.
2020-02-25 • Vaccine
2020-02-25 • Vaccine
BACKGROUND:
During a measles epidemic, the Ministry of Public Health (MOH) of the Democratic Republic of the Congo conducted supplementary immunization activities (2016-SIA) from Au...
Journal Article
|
Research

Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study

Coulborn RM, Gebrehiwot TG, Schneider M, Gerstl S, Adera C,  et al.
2018-11-08 • PLOS Neglected Tropical Diseases
2018-11-08 • PLOS Neglected Tropical Diseases
Ethiopia bears a high burden of visceral leishmaniasis (VL). Early access to VL diagnosis and care improves clinical prognosis and reduces transmission from infected humans; however, sig...
Conference Material
|
Video

Insights from an Ebola virus disease epidemic

Coulborn RM
2020-09-24 • Epicentre Scientific Day Paris 2020
2020-09-24 • Epicentre Scientific Day Paris 2020
Journal Article
|
Research

HIV Testing and Retention in Care of Infants Born to HIV- Infected Women Enrolled in 'Option B+', Thyolo, Malawi

Martínez Pérez G, Metcalf CJ, Garone DB, Coulborn RM, Harries AD,  et al.
2014-06-21 • Public Health Action
2014-06-21 • Public Health Action
Prevention of mother-to-child transmission 'Option B+' originated in Malawi in 2011 to prevent new infections in infants exposed to the human immunodeficiency virus (HIV). We assessed 12...
Journal Article
|
Research

Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia

Iwamoto M, Calzia A, Dublineau A, Rouet F, Nouhin J,  et al.
2018-12-03 • Journal of Viral Hepatitis
2018-12-03 • Journal of Viral Hepatitis
GeneXpert® (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point-of-care use in resource-limited conte...